18F-FDG PET/CT监测转移性血管周上皮样细胞肿瘤疾病进展
一例38岁女性胃肠道复发血管周上皮样细胞肿瘤(PECom)患者,多次腹内手术切除后行18F-FDG PET/CT,检出孤立盆腔转移灶但未见葡萄糖代谢增高或CT对比增强;后续随访PET/CT显示多发腹部转移并伴18F-FDG摄取明显增高,术中见广泛腹膜肉瘤病。该病例为转移性PECom疾病进展监测提供初步认识。
要点
- PECom盆腔转移灶可表现为18F-FDG摄取不高且CT不增强。
- 疾病进展时腹部多发转移灶可伴18F-FDG摄取明显增高。
- PET/CT表现与术中广泛腹膜肉瘤病相关。
核心结论
- 18F-FDG PET/CT可为转移性PECom疾病进展监测提供初步认识,但不同病灶18F-FDG摄取差异的病理生理基础尚未完全阐明。
研究设计与样本
- 单个病例报告:38岁女性,胃肠道复发性PECom多次腹内手术切除后行18F-FDG PET/CT及后续随访分期。
主要发现
- 首次PET/CT检出孤立盆腔转移灶,但该病灶未见葡萄糖消耗增高,CT亦无对比增强。
- 后续随访18F-FDG PET/CT分期显示多发腹部转移,此次伴18F-FDG摄取明显增高。
- 术中所见与后续PET/CT表现相关,为广泛腹膜肉瘤病。
临床怎么用
- 对转移性PECom患者,18F-FDG PET/CT可用于随访监测疾病进展,但需注意部分转移灶可能不表现为FDG摄取增高。
局限性
- 单例病例报告,样本量小,结论仅为初步认识。
- 不同病灶18F-FDG摄取差异的病理生理基础尚未完全理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 38-year-old woman presented for 18F-FDG PET/CT after multiple intra-abdominal surgical resections of a rare recurrent perivascular epithelioid cell tumor of the gastrointestinal tract. A solitary pelvic metastasis was detected, but surprisingly exhibited neither increased glucose consumption nor contrast enhancement on CT. Follow-up 18F-FDG PET/CT staging in the further disease course revealed multiple abdominal metastases, now, however, with markedly increased 18F-FDG uptake and intraoperatively correlating widespread peritoneal sarcomatosis. This case gives preliminary insight into monitoring of disease progression in metastatic perivascular epithelioid cell tumor, although the underlying pathophysiological bases for varying 18F-FDG uptake in PET/CT are not yet fully understood.
引用
- Holzgreve A, Fabritius MP, Knösel T, et al. 18F-FDG PET/CT for Monitoring of Disease Progression in Metastatic Perivascular Epithelioid Cell Tumor. Clin Nucl Med. 2021. PMID: 33315683. doi:10.1097/RLU.0000000000003453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。